Ghassan El-Haddad, MD

Associate Member Interventional Radiology, Head of Radionuclide Therapy Program
Moffitt Cancer Center and Research Institute

Presentation(s):

• Role of IO for Neuroendocrine Cancer

  Sunday, March 5, 2023
  3:42 PM – 3:48 PM

  Disclosure information not submitted.

• Long-Term Safety of Bland Embolization Prior to Peptide Receptor Radionuclide Therapy

  Sunday, March 5, 2023
  3:00 PM – 3:09 PM

  Disclosure(s): No relevant disclosure to display

• Pre-operative portal vein embolization to promote primary and secondary liver tumor resection

  Monday, March 6, 2023
  12:00 PM – 1:00 PM

  Disclosure information not submitted.

• Utility of Percutaneous Lung Nodule Biopsy in Patients with Known Non-Lung Primary Malignancy

  Monday, March 6, 2023
  12:00 PM – 1:00 PM

  Disclosure information not submitted.

• Transarterial Chemoperfusion Treatment of Unresectable Pleural Mesothelioma – a Phase 2 Prospective Study

  Monday, March 6, 2023
  4:03 PM – 4:12 PM

  Disclosure(s): No relevant disclosure to display

• Evolution in Management of Neuroendocrine Liver Metastases

  Tuesday, March 7, 2023
  8:30 AM – 10:00 AM

  Disclosure(s): No relevant disclosure to display

• Integration of PRRT and liver-directed therapies

  Tuesday, March 7, 2023
  8:43 AM – 8:56 AM

  Disclosure(s): No relevant disclosure to display